View in EDS HTML Full Text PDF Full Text

ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines.

Saved in:
Bibliographic Details
Title: ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines.
Authors: Cortese, Samuele, Coghill, David, Fegert, Joerg M., Mattingly, Gregory W., Rohde, Luis A., Wong, Ian C.K., Faraone, Stephen V.
Source: European Child & Adolescent Psychiatry. May2024, Vol. 33 Issue 5, p1605-1608. 4p.
Subjects: World Health Organization, Medical protocols, Essential drugs, Attention-deficit hyperactivity disorder, Drug approval, Methylphenidate, Public health, Union catalogs, Comorbidity, Medical care costs
Abstract: The article focuses on the economic and health impacts of Attention-Deficit/Hyperactivity Disorder (ADHD) and highlights the debate regarding the inclusion of methylphenidate in critical medication lists. Topics include the substantial societal costs of ADHD, the effectiveness and safety of methylphenidate in managing the disorder, and the concerns about its exclusion from the World Health Organization's (WHO) Essential Medicines List and the European Union's Union List of critical medicines.
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 178046272
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Cortese%2C+Samuele%22">Cortese, Samuele</searchLink><br /><searchLink fieldCode="AR" term="%22Coghill%2C+David%22">Coghill, David</searchLink><br /><searchLink fieldCode="AR" term="%22Fegert%2C+Joerg+M%2E%22">Fegert, Joerg M.</searchLink><br /><searchLink fieldCode="AR" term="%22Mattingly%2C+Gregory+W%2E%22">Mattingly, Gregory W.</searchLink><br /><searchLink fieldCode="AR" term="%22Rohde%2C+Luis+A%2E%22">Rohde, Luis A.</searchLink><br /><searchLink fieldCode="AR" term="%22Wong%2C+Ian+C%2EK%2E%22">Wong, Ian C.K.</searchLink><br /><searchLink fieldCode="AR" term="%22Faraone%2C+Stephen+V%2E%22">Faraone, Stephen V.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Child+%26+Adolescent+Psychiatry%22">European Child & Adolescent Psychiatry</searchLink>. May2024, Vol. 33 Issue 5, p1605-1608. 4p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22World+Health+Organization%22">World Health Organization</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+protocols%22">Medical protocols</searchLink><br /><searchLink fieldCode="DE" term="%22Essential+drugs%22">Essential drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Attention-deficit+hyperactivity+disorder%22">Attention-deficit hyperactivity disorder</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+approval%22">Drug approval</searchLink><br /><searchLink fieldCode="DE" term="%22Methylphenidate%22">Methylphenidate</searchLink><br /><searchLink fieldCode="DE" term="%22Public+health%22">Public health</searchLink><br /><searchLink fieldCode="DE" term="%22Union+catalogs%22">Union catalogs</searchLink><br /><searchLink fieldCode="DE" term="%22Comorbidity%22">Comorbidity</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+care+costs%22">Medical care costs</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The article focuses on the economic and health impacts of Attention-Deficit/Hyperactivity Disorder (ADHD) and highlights the debate regarding the inclusion of methylphenidate in critical medication lists. Topics include the substantial societal costs of ADHD, the effectiveness and safety of methylphenidate in managing the disorder, and the concerns about its exclusion from the World Health Organization's (WHO) Essential Medicines List and the European Union's Union List of critical medicines.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=178046272
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00787-024-02443-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 1605
    Subjects:
      – SubjectFull: World Health Organization
        Type: general
      – SubjectFull: Medical protocols
        Type: general
      – SubjectFull: Essential drugs
        Type: general
      – SubjectFull: Attention-deficit hyperactivity disorder
        Type: general
      – SubjectFull: Drug approval
        Type: general
      – SubjectFull: Methylphenidate
        Type: general
      – SubjectFull: Public health
        Type: general
      – SubjectFull: Union catalogs
        Type: general
      – SubjectFull: Comorbidity
        Type: general
      – SubjectFull: Medical care costs
        Type: general
    Titles:
      – TitleFull: ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cortese, Samuele
      – PersonEntity:
          Name:
            NameFull: Coghill, David
      – PersonEntity:
          Name:
            NameFull: Fegert, Joerg M.
      – PersonEntity:
          Name:
            NameFull: Mattingly, Gregory W.
      – PersonEntity:
          Name:
            NameFull: Rohde, Luis A.
      – PersonEntity:
          Name:
            NameFull: Wong, Ian C.K.
      – PersonEntity:
          Name:
            NameFull: Faraone, Stephen V.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 10188827
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: European Child & Adolescent Psychiatry
              Type: main
ResultId 1